MarketCap
Facebook
X
Telegram
Akouos Depreciation & Amortization | AKUS
Annual Depreciation & Amortization Akouos
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.49 M | 1.92 M | 361 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.49 M | 361 K | 1.59 M |
Quarterly Depreciation & Amortization Akouos
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 800 K | 800 K | 748 K | - | 748 K | 500 K | 544 K | - | 500 K | 500 K | 446 K | - | 100 K | 103 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 800 K | 100 K | 526 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Happiness Biotech Group Limited
HAPP
|
380 K | - | 1.35 % | $ 17.8 M |  China |
 |
Dynavax Technologies Corporation
DVAX
|
4.63 M | - | - | $ 2.02 B |  USA |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | China |
 |
Deciphera Pharmaceuticals
DCPH
|
2.1 M | - | - | $ 2.18 B | USA |
 |
Alpine Immune Sciences
ALPN
|
576 K | - | - | $ 2.17 B | USA |
 |
AstraZeneca PLC
AZN
|
5.73 B | - | - | $ 96.9 B |  Britain |
 |
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | USA |
 |
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | USA |
 |
Geron Corporation
GERN
|
474 K | $ 1.42 | -2.07 % | $ 947 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | USA |
 |
Inhibikase Therapeutics
IKT
|
60.5 K | $ 2.33 | - | $ 229 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
4.7 M | - | -1.58 % | $ 28.1 M | China |
 |
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
4.93 M | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M |  Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
5 K | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
1.74 M | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
58.8 M | - | - | $ 3.37 B | China |
 |
Jaguar Health
JAGX
|
1.91 M | $ 0.96 | -6.48 % | $ 2.24 M | USA |
 |
Johnson & Johnson
JNJ
|
7.5 B | $ 263.4 | 1.58 % | $ 634 B | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Alkermes plc
ALKS
|
27.2 M | $ 52.89 | -0.15 % | $ 8.71 B |  Irlanda |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
Achieve Life Sciences
ACHV
|
228 K | $ 6.1 | -1.13 % | $ 266 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |